About the Authors

Soo-Huey Yap, Jonathan Fahey, Mark Zanin, David Tyssen, Gilda Tachedjian
Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia

Soo-Huey Yap
School of Applied Sciences and Engineering, Monash University, Churchill, Victoria, Australia

Chih-Wei Sheen, Nicolas Sluis-Cremer
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

Jonathan Fahey, Gilda Tachedjian
Department of Microbiology, Monash University, Clayton, Victoria, Australia

Viviane Dias Lima, Brian Wynhoven, P. Richard Harrigan
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Michael Kuiper
Victorian Partnership for Advanced Computing, Carlton South, Victoria, Australia

Gilda Tachedjian
Department of Medicine, Monash University, Melbourne, Victoria, Australia

Corresponding Author

gildat@burnet.edu.au

Competing Interests

PRH has received honoraria, research and travel grants and served as a speaker from many pharmaceutical companies, and has served as a consultant to HIV drug resistance testing companies including Virco and Monogram Biosciences. SHY, CWS, JF, MZ, DT, VDL, BW, MK, NSC, and GT declare no competing interests.

Author Contributions

GT, PRH, NSC, and SHY designed the study. PRH and BW gathered the clinical data, and SHY, DT, JF, MZ, and CWS performed the experiments. GT, SHY, PRH, and VDL performed the statistical analyses. MK performed the structural analyses, and GT, NSC, PRH, SHY, and VDL contributed to writing the paper and analysing the data.